Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (CY503C2)

This study has been terminated.
(The sponsor declared the early termination of the study due to poor recruitment of patients.)
Sponsor:
Collaborators:
ClinAssess GmbH
Medical University Innsbruck
Charite University, Berlin, Germany
Information provided by:
Cytavis Biopharma GmbH
ClinicalTrials.gov Identifier:
NCT00932724
First received: June 25, 2009
Last updated: July 9, 2013
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)